Cannabis research has reached unprecedented levels, with over 35,000 peer-reviewed studies published in the past decade. So when some say we don’t know the risks with cannabis, it seems not to be true.
A recent analysis by NORML highlights the growing importance of cannabis in scientific and medical discussions, showcasing its potential benefits, risks, and challenges.
Breakthroughs in the last decade
The past ten years have seen an exponential rise in cannabis research, with studies focusing on:
- Medical uses: Relief for chronic pain, anxiety, epilepsy, and more.
- Public health: Effects on mental health, cognition, and societal outcomes.
- Economic impact: Benefits of legalization and industry growth.
- Social trends: Shifts in consumption patterns and demographics.
Global collaboration
Research institutions globally have contributed, with countries like Canada and Israel leading in medical and societal studies. This international effort reflects cannabis’s widespread impact.
Challenges remain
In the U.S., federal restrictions hinder research due to cannabis’s Schedule I classification. These barriers limit funding, access, and study opportunities, slowing progress.
Advocates argue for federal reforms to enable broader, evidence-based research, helping policymakers better understand cannabis’s risks and benefits.
The future of cannabis research
With over 35,000 studies, cannabis discussions are increasingly grounded in evidence. Supporting research will further advance healthcare, legislation, and societal understanding, making cannabis one of the most transformative plants of our time.